CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks (Q38472331)

3 September 2017

1 reference

title

CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks (English)

1 reference

3 September 2017

F Guo

1 reference

3 September 2017

Y Wang

1 reference

3 September 2017

J Liu

1 reference

3 September 2017

S C Mok

1 reference

3 September 2017

F Xue

1 reference

3 September 2017

W Zhang

1 reference

3 September 2017

language of work or name

English

0 references

publication date

11 May 2015

1 reference

3 September 2017

1 reference

3 September 2017

1 reference

3 September 2017

1 reference

3 September 2017

page(s)

816-826

1 reference

3 September 2017

cites work

Cancer statistics, 2014

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Role of chemokine network in the development and progression of ovarian cancer: a potential novel pharmacological target

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

curatedOvarianData: clinically annotated data for the ovarian cancer transcriptome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

OvMark: a user-friendly system for the identification of prognostic biomarkers in publically available ovarian cancer gene expression datasets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Cancer-associated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-β signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Absence of activating mutations of CXCR4 in pituitary tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Genetic variation in CXCR4 and risk of chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

A point mutation (G574A) in the chemokine receptor CXCR4 detected in human cancer cells enhances migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Sequential genetic change at the TP53 and chemokine receptor CXCR4 locus during transformation of human ovarian surface epithelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

CXCR7 impact on CXCL12 biology and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Chemokine receptor CXCR7 is a functional receptor for CXCL12 in brain endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

CXCR7 stimulates MAPK signaling to regulate hepatocellular carcinoma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Increased expression of SDF-1/CXCR4 is associated with lymph node metastasis of invasive micropapillary carcinoma of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

The chemokine receptor CXCR4 is expressed in pancreatic intraepithelial neoplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Stromal cell-derived factor-1 (SDF-1)/CXCR4 axis enhances cellular invasion in ovarian carcinoma cells via integrin β1 and β3 expressions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Expression of the CXCL12/CXCR4 and CXCL16/CXCR6 axes in cervical intraepithelial neoplasia and cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Expression of CXCR4 in oral squamous cell carcinoma: correlations with clinicopathology and pivotal role of proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Microenvironmental regulation of chemokine (C-X-C-motif) receptor 4 in ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

A taxonomy of organ-specific breast cancer metastases based on a protein-protein interaction network

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Serum ENA78/CXCL5, SDF-1/CXCL12, and their combinations as potential biomarkers for prediction of the presence and distant metastasis of primary gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

CXCL12 and TP53 genetic polymorphisms as markers of susceptibility in a Brazilian children population with acute lymphoblastic leukemia (ALL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Expression of angiogenic chemokines in ovarian clear cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

The intricate role of CXCR4 in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

CXCL12 and CXCR4 in adenocarcinoma of the lung: association with metastasis and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

CXCL12 (SDF1α)-CXCR4/CXCR7 Pathway Inhibition: An Emerging Sensitizer for Anticancer Therapies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

SDF-1/CXCR7 axis enhances ovarian cancer cell invasion by MMP-9 expression through p38 MAPK pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Down-Regulation of CXCL12 by DNA Hypermethylation and Its Involvement in Gastric Cancer Metastatic Progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Simultaneous CXCL12 and ESR1 CpG island hypermethylation correlates with poor prognosis in sporadic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Epigenetic changes of CXCR4 and its ligand CXCL12 as prognostic factors for sporadic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Tamoxifen epigenetically modulates CXCL12 expression in MCF-7 breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Differential estrogen-regulation of CXCL12 chemokine receptors, CXCR4 and CXCR7, contributes to the growth effect of estrogens in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

c-myb activates CXCL12 transcription in T47D and MCF7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

SLUG promotes prostate cancer cell migration and invasion via CXCR4/CXCL12 axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Hypoxia-inducible factor-2 is a novel regulator of aberrant CXCL12 expression in multiple myeloma plasma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

p53 activation of mesenchymal stromal cells partially abrogates microenvironment-mediated resistance to FLT3 inhibition in AML through HIF-1α-mediated down-regulation of CXCL12

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

p53 Attenuates cancer cell migration and invasion through repression of SDF-1/CXCL12 expression in stromal fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Breast cancer metastasis: demonstration that FOXP3 regulates CXCR4 expression and the response to CXCL12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Cancer-derived lysophosphatidic acid stimulates differentiation of human mesenchymal stem cells to myofibroblast-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Endolyn (CD164) modulates the CXCL12-mediated migration of umbilical cord blood CD133+ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Inhibiting CD164 expression in colon cancer cell line HCT116 leads to reduced cancer cell proliferation, mobility, and metastasis in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

CD164 regulates the tumorigenesis of ovarian surface epithelial cells through the SDF-1α/CXCR4 axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

HOXA9 promotes ovarian cancer growth by stimulating cancer-associated fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

CD40 signal regulates CXCR4 mediating ovarian carcinoma cell migration: implications for extrapelvic metastastic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

CD24⁺ ovary cancer cells exhibit an invasive mesenchymal phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

MiR-1 is a tumor suppressor in thyroid carcinogenesis targeting CCND2, CXCR4, and SDF-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Exosomal shuttling of miR-126 in endothelial cells modulates adhesive and migratory abilities of chronic myelogenous leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

MicroRNA-140 expression during chondrogenic differentiation of equine cord blood-derived mesenchymal stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

miR-146a-5p circuitry uncouples cell proliferation and migration, but not differentiation, in human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

miR-27b represses migration of mouse MSCs to burned margins and prolongs wound repair through silencing SDF-1a

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

miRNA regulation of Sdf1 chemokine signaling provides genetic robustness to germ cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

MiR-886-3p down regulates CXCL12 (SDF1) expression in human marrow stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

miR-9 targets CXCR4 and functions as a potential tumor suppressor in nasopharyngeal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

MicroRNA-9 inhibits the proliferation of oral squamous cell carcinoma cells by suppressing expression of CXCR4 via the Wnt/β-catenin signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

MicroRNA-146a and AMD3100, two ways to control CXCR4 expression in acute myeloid leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

MicroRNA-494-3p targets CXCR4 to suppress the proliferation, invasion, and migration of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

miR-133b, a muscle-specific microRNA, is a novel prognostic marker that participates in the progression of human colorectal cancer via regulation of CXCR4 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

MiR-139 targets CXCR4 and inhibits the proliferation and metastasis of laryngeal squamous carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Deficits in microRNA-mediated Cxcr4/Cxcl12 signaling in neurodevelopmental deficits in a 22q11 deletion syndrome mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

CXCR4 inhibitors: tumor vasculature and therapeutic challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Ovulation and extra-ovarian origin of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

CXCL12 expression by healthy and malignant ovarian epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12) stimulates ovarian cancer cell growth through the EGF receptor transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

CXCR4 activation induces epidermal growth factor receptor transactivation in an ovarian cancer cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

LRRC4 inhibits human glioblastoma cells proliferation, invasion, and proMMP-2 activation by reducing SDF-1 alpha/CXCR4-mediated ERK1/2 and Akt signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Blockade of SDF-1/CXCR4 signalling inhibits pancreatic cancer progression in vitro via inactivation of canonical Wnt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

The alpha-chemokine, stromal cell-derived factor-1alpha, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Co-evolution of tumor cells and their microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

The chemokine receptor CXCR4 and the metalloproteinase MT1-MMP are mutually required during melanoma metastasis to lungs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Leukemia Stem Cells and Microenvironment: Biology and Therapeutic Targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Multiple myeloma cells recruit tumor-supportive macrophages through the CXCR4/CXCL12 axis and promote their polarization toward the M2 phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Macrophages may promote cancer growth via a GM-CSF/HB-EGF paracrine loop that is enhanced by CXCL12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell‐mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Diverse signaling pathways through the SDF-1/CXCR4 chemokine axis in prostate cancer cell lines leads to altered patterns of cytokine secretion and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

A glycolytic mechanism regulating an angiogenic switch in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12)-enhanced angiogenesis of human basal cell carcinoma cells involves ERK1/2-NF-kappaB/interleukin-6 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Interleukin-6 induced basic fibroblast growth factor-dependent angiogenesis in basal cell carcinoma cell line via JAK/STAT3 and PI3-kinase/Akt pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Interleukin 6 induces the expression of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

SDF-1/CXCR4 signaling up-regulates survivin to regulate human sacral chondrosarcoma cell cycle and epithelial-mesenchymal transition via ERK and PI3K/AKT pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

SDF-1/CXCR4 promotes epithelial-mesenchymal transition and progression of colorectal cancer by activation of the Wnt/β-catenin signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

The SDF-1/CXCR4 axis induces epithelial–mesenchymal transition in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

SDF-1/CXCR4 signaling induces pancreatic cancer cell invasion and epithelial-mesenchymal transition in vitro through non-canonical activation of Hedgehog pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Involvement of chemokine receptors in breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Cancer and the chemokine network

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

The CXCR4/CXCL12 axis in endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Isoform-selective phosphoinositide 3'-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell-mediated drug resistance in chronic lymphocytic leukemia: a novel therapeutic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

PI3Kgamma activation by CXCL12 regulates tumor cell adhesion and invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Uterine smooth muscle cells increase invasive ability of endometrial carcinoma cells through tumor-stromal interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Fusion-derived epithelial cancer cells express hematopoietic markers and contribute to stem cell and migratory phenotype in ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Stromal cell-derived factor-1 (SDF-1) enhances cells invasion by αvβ6 integrin-mediated signaling in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

CXCL12/SDF-1 alpha activates NF-kappaB and promotes oral cancer invasion through the Carma3/Bcl10/Malt1 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Stromal-cell derived factor-1 regulates epithelial ovarian cancer cell invasion by activating matrix metalloproteinase-9 and matrix metalloproteinase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

The role of SDF-1/CXCR4 axis in ovarian cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Binding of lymphoid chemokines to collagen IV that accumulates in the basal lamina of high endothelial venules: its implications in lymphocyte trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Hypoxia differentially regulated CXCR4 and CXCR7 signaling in colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

The disparate twins: a comparative study of CXCR4 and CXCR7 in SDF-1α-induced gene expression, invasion and chemosensitivity of colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Chemokine receptors in gastric MALT lymphoma: loss of CXCR4 and upregulation of CXCR7 is associated with progression to diffuse large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

The multiple faces of CXCL12 (SDF-1alpha) in the regulation of immunity during health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Expression and regulation of the orphan receptor RDC1 and its putative ligand in human dendritic and B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

CXCL12/CXCR4 blockade by oncolytic virotherapy inhibits ovarian cancer growth by decreasing immunosuppression and targeting cancer-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Targeting CXCL12/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Mast cells mediate the immune suppression induced by dermal exposure to JP-8 jet fuel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Pharmacologically antagonizing the CXCR4-CXCL12 chemokine pathway with AMD3100 inhibits sunlight-induced skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

AMD3100 protects from UV-induced skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Regulatory T cells in the bone marrow microenvironment in patients with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

CXCL12 Mediates Immunosuppression in the Lymphoma Microenvironment after Allogeneic Transplantation of Hematopoietic Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

CXCR4 inhibition synergizes with cytotoxic chemotherapy in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

CXCR4 regulates growth of both primary and metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Noninvasive imaging reveals inhibition of ovarian cancer by targeting CXCL12-CXCR4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

CXCL12/CXCR4 blockade induces multimodal antitumor effects that prolong survival in an immunocompetent mouse model of ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Inhibition of the SDF-1alpha-CXCR4 axis by the CXCR4 antagonist AMD3100 suppresses the migration of cultured cells from ATL patients and murine lymphoblastoid cells from HTLV-I Tax transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Determination of the binding mode for the cyclopentapeptide CXCR4 antagonist FC131 using a dual approach of ligand modifications and receptor mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

An antagonist of the chemokine receptor CXCR4 induces mitotic catastrophe in ovarian cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Direct evidence that bevacizumab, an anti-VEGF antibody, up-regulates SDF1alpha, CXCR4, CXCL6, and neuropilin 1 in tumors from patients with rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Induction of a tumor-metastasis-receptive microenvironment as an unwanted and underestimated side effect of treatment by chemotherapy or radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Imaging CXCL12-CXCR4 signaling in ovarian cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

CXCR4 inhibition with AMD3100 sensitizes prostate cancer to docetaxel chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

The Spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with chronic lymphocytic leukemia cell motility and causes chemosensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Blockade of SDF-1 after irradiation inhibits tumor recurrences of autochthonous brain tumors in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Hematopoietic stem and progenitor cell mobilization in mice and humans by a first-in-class mirror-image oligonucleotide inhibitor of CXCL12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

SDF-1 inhibition targets the bone marrow niche for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

High levels of expression of human stromal cell-derived factor-1 are associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Chemokine axes CXCL12/CXCR4 and CXCL16/CXCR6 correlate with lymph node metastasis in epithelial ovarian carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Genetic and cytokine changes associated with symptomatic stages of CLL

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

CCL27-CCR10 and CXCL12-CXCR4 chemokine ligand-receptor mRNA expression ratio: new predictive factors of tumor progression in cutaneous malignant melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Expression of SDF-1 and CXCR4 transcript variants and CXCR7 in epithelial ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Expression of CXCR4 is associated with axillary lymph node status in patients with early breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Down-regulation of CXCL12 mRNA expression by promoter hypermethylation and its association with metastatic progression in human breast carcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Possible involvement of SDF-1alpha/CXCR4-DPPIV axis in TGF-beta1-induced enhancement of migratory potential in human peritoneal mesothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

P53 regulates the migration of mesenchymal stromal cells in response to the tumor microenvironment through both CXCL12-dependent and -independent mechanisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Effect of the LPA-mediated CXCL12-CXCR4 axis in the tumor proliferation, migration and invasion of ovarian cancer cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Interleukin-2 administration alters the CD4+FOXP3+ T-cell pool and tumor trafficking in patients with ovarian carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

miR-141 Regulates colonic leukocytic trafficking by targeting CXCL12β during murine colitis and human Crohn's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

MicroRNA-126 functions as a tumor suppressor in colorectal cancer cells by targeting CXCR4 via the AKT and ERK1/2 signaling pathways

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

MicroRNA-150 protects the heart from injury by inhibiting monocyte accumulation in a mouse model of acute myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

RETRACTED: SDF-1/CXCR4 Axis Regulates Cell Cycle Progression and Epithelial-Mesenchymal Transition via Up-regulation of Survivin in Glioblastoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Possible role of stromal-cell-derived factor-1/CXCR4 signaling on lymph node metastasis of oral squamous cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

CXC chemokine receptor-4 antagonist blocks both growth of primary tumor and metastasis of head and neck cancer in xenograft mouse models

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Involvement of SDF-1alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

Plerixafor (AMD3100) induces prolonged mobilization of acute lymphoblastic leukemia cells and increases the proportion of cycling cells in the blood in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.139

[Relationship between chemokine axis CXCL12-CXCR4 and epithelial ovarian cancer]

31 March 2020

1 reference

12 December 2020

[Effect of chemokine CXCL12 and its receptor CXCR4 on proliferation, migration and invasion of epithelial ovarian cancer cells].

1 reference

12 December 2020

Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt

1 reference

12 December 2020

The sialomucin CD164 (MGC-24v) is an adhesive glycoprotein expressed by human hematopoietic progenitors and bone marrow stromal cells that serves as a potent negative regulator of hematopoiesis

1 reference

12 December 2020

Epithelial cancer cell migration: a role for chemokine receptors?

1 reference

12 December 2020

Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer

1 reference

12 December 2020

Insights on the CXCL12-CXCR4 axis in hepatocellular carcinoma carcinogenesis

1 reference

12 December 2020

SDF-1alpha/CXCL12 and dendritic cells in ovarian cancer microenvironment

1 reference

12 December 2020

CXCL12 chemokine and its receptors as major players in the interactions between immune and nervous systems

1 reference

12 December 2020

Expression of CXCR4 and its ligand SDF-1 in intestinal-type gastric cancer is associated with lymph node and liver metastasis

1 reference

12 December 2020

Gene expression profile of ovarian serous papillary carcinomas: identification of metastasis-associated genes

1 reference

12 December 2020

CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers.

1 reference

12 December 2020

miR-199a-5p regulates the expression of metastasis-associated genes in B16F10 melanoma cells

1 reference

12 December 2020

https://api.fatcat.wiki/v0/release/yygev72axbb7hnt6b65wzuy2ce

Identifiers

1 reference

30 July 2022

mapped directly with Wikidata item

Dimensions Publication ID

1014813615

0 references

Fatcat ID

release_yygev72axbb7hnt6b65wzuy2ce

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yygev72axbb7hnt6b65wzuy2ce

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/yygev72axbb7hnt6b65wzuy2ce

1 reference

30 July 2022